FOLD — Amicus Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Amicus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	483	482	294	286	250
Net Total Accounts Receivable
Net Total Receivables	46.9	52.7	66.2	87.6	101
Total Inventory
Prepaid Expenses
Total Current Assets	579	597	424	483	505
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	67.2	63.1	60.3	58	51.7
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	887	905	724	778	785
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	130	146	139	168	149
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	600	598	601	618	591
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	286	307	123	160	194
Total Liabilities & Shareholders' Equity	887	905	724	778	785
Total Common Shares Outstanding